Grant: Idea to Innovation
University of Waterloo
$15,000.00
Market assessment of water-soluble chromogenic substrates for detecting bacterial beta-lactamases
FY 2020-21
Summary
Beta-lactam antibiotics such as penicillins and cephalosporins are the most widely prescribed pharmaceuticals for treating potentially life-threatening bacterial infections. Human pathogenic bacteria are becoming increasingly resistant to antibiotics in general. In the case of the beta-lactam antibiotics, the main cause of antibiotic resistance is the ability of bacteria to produce enzymes called beta-lactamases that catalyze a chemical reaction of the beta-lactam with water resulting in the destruction of the ability of these pharmaceuticals to act as antibiotics.
Recent research at the University of Waterloo has led to the discovery of a synthetic compound, now called Aubergen2, that undergoes a very dramatic (chromogenic) colour change from yellow to deep purple in the presence of bacterial beta-lactamases thus allowing for a very rapid visual method for detecting the presence of bacteria that are resistant to beta-lactam antibiotics. Aubergen2 has the potential to provide substantial improvement in the area of visual detection of antibiotic resistance to guide the choice of the most appropriate antibiotics for treatment of bacterial infections.
Additionally, this chromogenic compound has much potential for use in the discovery of inhibitors of the bacterial beta-lactamases that can be administered along with beta-lactam antibiotics to overcome antibacterial resistance as well as in new biotechnological methods in areas as diverse as virus detection to detection of asbestos.
This proposal seeks to enlist an independent group to carry out a market analysis to determine if this technology has the potential to be competitive in the Canadian and world-wide markets for chromogenic enzyme substrates.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
560497-2021
Name nom
Dmitrienko, Gary
Department département
Chemistry
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2021
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Market assessment of water-soluble chromogenic substrates for detecting bacterial beta-lactamases
Keyword
NSERC
Application summary
Beta-lactam antibiotics such as penicillins and cephalosporins are the most widely prescribed pharmaceuticals for treating potentially life-threatening bacterial infections. Human pathogenic bacteria are becoming increasingly resistant to antibiotics in general. In the case of the beta-lactam antibiotics, the main cause of antibiotic resistance is the ability of bacteria to produce enzymes called beta-lactamases that catalyze a chemical reaction of the beta-lactam with water resulting in the destruction of the ability of these pharmaceuticals to act as antibiotics.
Recent research at the University of Waterloo has led to the discovery of a synthetic compound, now called Aubergen2, that undergoes a very dramatic (chromogenic) colour change from yellow to deep purple in the presence of bacterial beta-lactamases thus allowing for a very rapid visual method for detecting the presence of bacteria that are resistant to beta-lactam antibiotics. Aubergen2 has the potential to provide substantial improvement in the area of visual detection of antibiotic resistance to guide the choice of the most appropriate antibiotics for treatment of bacterial infections.
Additionally, this chromogenic compound has much potential for use in the discovery of inhibitors of the bacterial beta-lactamases that can be administered along with beta-lactam antibiotics to overcome antibacterial resistance as well as in new biotechnological methods in areas as diverse as virus detection to detection of asbestos.
This proposal seeks to enlist an independent group to carry out a market analysis to determine if this technology has the potential to be competitive in the Canadian and world-wide markets for chromogenic enzyme substrates.